{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:07:38Z","timestamp":1779084458752,"version":"3.51.4"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The Epstein-Barr virus (EBV) is an oncogenic herpesvirus that establishes lifelong infections in more than 90% of the human population. EBV infection is typically diagnosed using serological assays, which also distinguish between acute and persistent infection. However, current diagnostic approaches rely on a limited set of viral proteins and may therefore fail to detect disease-specific antibody signatures associated with EBV-related cancers or autoimmune diseases. Comprehensive profiling of humoral responses against the complete EBV proteome could improve the sensitivity and specificity of serological diagnostics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We developed a serological multiplex assay covering all EBV proteins expressed in human cells, enabling measurement of virus-specific IgM, IgG, and IgA responses. The assay was evaluated using sera from healthy EBV carriers and EBV-negative controls. Near-infrared detection was employed to support quantitative analysis across a broad dynamic range. Performance was benchmarked against commercially available serological assays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The multiplex assay demonstrated a broad dynamic range with linear quantification across several orders of magnitude. Comparative evaluation showed that the assay achieved sensitivity and specificity comparable to established commercial tests while enabling comprehensive antibody profiling against the full EBV proteome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This multiplex serological platform provides a robust approach for comprehensive characterization of EBV-specific humoral immune responses. By extending antibody profiling beyond the limited antigen panels used in routine diagnostics, the assay may facilitate the identification of novel biomarkers for EBV-associated cancers and autoimmune diseases. Future applications could contribute to improved diagnostic accuracy and support the development of targeted therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1829807","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T05:41:46Z","timestamp":1779082906000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel multiplex approach for the comprehensive analysis of the Epstein-Barr virus-specific humoral immune response"],"prefix":"10.3389","volume":"16","author":[{"given":"Carola","family":"Meindl","sequence":"first","affiliation":[{"name":"Children\u2019s Hospital, School of Medicine, Technische Universit\u00e4t M\u00fcnchen, Munich","place":["Munich, Germany"]},{"name":"German Centre for Infection Research, Deutsches Zentrum f\u00fcr Infektionsforschung (DZIF), Partner Site Munich","place":["Munich, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramona","family":"Weggel","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, School of Medicine, Technische Universit\u00e4t M\u00fcnchen, Munich","place":["Munich, Germany"]},{"name":"German Centre for Infection Research, Deutsches Zentrum f\u00fcr Infektionsforschung (DZIF), Partner Site Munich","place":["Munich, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolin","family":"Deichl","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, School of Medicine, Technische Universit\u00e4t M\u00fcnchen, Munich","place":["Munich, Germany"]},{"name":"German Centre for Infection Research, Deutsches Zentrum f\u00fcr Infektionsforschung (DZIF), Partner Site Munich","place":["Munich, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin Maria","family":"Fleischer","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, School of Medicine, Technische Universit\u00e4t M\u00fcnchen, Munich","place":["Munich, Germany"]},{"name":"Institute of Virology, School of Medicine, Technische Universit\u00e4t M\u00fcnchen & Helmholtz Zentrum M\u00fcnchen","place":["Munich, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Hofmeier","sequence":"additional","affiliation":[{"name":"Institute of Virology, School of Medicine, Technische Universit\u00e4t M\u00fcnchen & Helmholtz Zentrum M\u00fcnchen","place":["Munich, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette","family":"Last","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, School of Medicine, Technische Universit\u00e4t M\u00fcnchen, Munich","place":["Munich, Germany"]},{"name":"Institute of Virology, School of Medicine, Technische Universit\u00e4t M\u00fcnchen & Helmholtz Zentrum M\u00fcnchen","place":["Munich, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julius","family":"N\u00fcckel","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, School of Medicine, Technische Universit\u00e4t M\u00fcnchen, Munich","place":["Munich, Germany"]},{"name":"German Centre for Infection Research, Deutsches Zentrum f\u00fcr Infektionsforschung (DZIF), Partner Site Munich","place":["Munich, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Planatscher","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, School of Medicine, Technische Universit\u00e4t M\u00fcnchen, Munich","place":["Munich, Germany"]},{"name":"German Centre for Infection Research, Deutsches Zentrum f\u00fcr Infektionsforschung (DZIF), Partner Site Munich","place":["Munich, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lobna Ali","family":"Onsi","sequence":"additional","affiliation":[{"name":"Institute of Virology, School of Medicine, Technische Universit\u00e4t M\u00fcnchen & Helmholtz Zentrum M\u00fcnchen","place":["Munich, Germany"]},{"name":"Department of Microbiology and Immunology, German University in Cairo","place":["Cairo, Egypt"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Sch\u00fctt","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, School of Medicine, Technische Universit\u00e4t M\u00fcnchen, Munich","place":["Munich, Germany"]},{"name":"German Centre for Infection Research, Deutsches Zentrum f\u00fcr Infektionsforschung (DZIF), Partner Site Munich","place":["Munich, Germany"]},{"name":"Institute of Virology, School of Medicine, Technische Universit\u00e4t M\u00fcnchen & Helmholtz Zentrum M\u00fcnchen","place":["Munich, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uta","family":"Behrends","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, School of Medicine, Technische Universit\u00e4t M\u00fcnchen, Munich","place":["Munich, Germany"]},{"name":"German Centre for Infection Research, Deutsches Zentrum f\u00fcr Infektionsforschung (DZIF), Partner Site Munich","place":["Munich, Germany"]},{"name":"Institute of Virology, School of Medicine, Technische Universit\u00e4t M\u00fcnchen & Helmholtz Zentrum M\u00fcnchen","place":["Munich, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Mautner","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, School of Medicine, Technische Universit\u00e4t M\u00fcnchen, Munich","place":["Munich, Germany"]},{"name":"German Centre for Infection Research, Deutsches Zentrum f\u00fcr Infektionsforschung (DZIF), Partner Site Munich","place":["Munich, Germany"]},{"name":"Institute of Virology, School of Medicine, Technische Universit\u00e4t M\u00fcnchen & Helmholtz Zentrum M\u00fcnchen","place":["Munich, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000583","article-title":"Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy","volume":"2","author":"Adhikary","year":"2007","journal-title":"PloS One"},{"key":"B2","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/b978-0-443-07367-0.00093-8","article-title":"Avidities of IgG directed against viral capsid antigen or early antigen: useful markers for significant Epstein-Barr virus serology","volume":"43","author":"Andersson","year":"1994","journal-title":"J. Med. Virol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/s0140-6736(87)91525-x","article-title":"Simplicity through complexity: immunoblot with recombinant antigens as the new gold standard in Epstein-Barr virus serology","volume":"47","author":"Bauer","year":"2001","journal-title":"Clin. Lab."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-023-00775-5","article-title":"Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications","volume":"19","author":"Bjornevik","year":"2023","journal-title":"Nat. Rev. Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1212\/wnl.0000000000202361","article-title":"A systematic review of Epstein-Barr virus antibodies as clinical biomarkers in multiple sclerosis (P1-3.007)","volume":"100","author":"Bose","year":"2023","journal-title":"Neurology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/aje\/kwu176","article-title":"Epstein-Barr virus antibodies and the risk of associated Malignancies: review of the literature","volume":"180","author":"Coghill","year":"2014","journal-title":"Am. J. Epidemiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1158\/1078-0432.ccr-17-1929","article-title":"Identification of a novel, EBV-based antibody risk stratification signature for\u00a0early detection of nasopharyngeal carcinoma in Taiwan","volume":"24","author":"Coghill","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.bj.2020.10.009","article-title":"Modified ELISA for antibody avidity evaluation: the need for standardization","volume":"44","author":"Correa","year":"2021","journal-title":"Biomed. J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1016\/j.cell.2022.08.026","article-title":"Epstein-Barr virus: biology and clinical disease","volume":"185","author":"Damania","year":"2022","journal-title":"Cell."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1128\/jvi.69.2.1265-1270.1995","article-title":"Characterization of the Epstein-Barr virus proteinase and comparison with the human cytomegalovirus proteinase","volume":"69","author":"Donaghy","year":"1995","journal-title":"J. Virol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s12026-018-9045-0","article-title":"Molecular mimicry, genetic homology, and gene sharing proteomic \u201cmolecular fingerprints\u201d using an EBV (Epstein-Barr virus)-derived microarray as a potential diagnostic method in autoimmune disease","volume":"66","author":"Dreyfus","year":"2018","journal-title":"Immunol. Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0042-6822(88)90509-0","article-title":"Antigenic analysis of the Epstein-Barr virus major membrane antigen (gp350\/220) expressed in yeast and mammalian cells: implications for the development of a subunit vaccine","volume":"166","author":"Emini","year":"1988","journal-title":"Virology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1128\/jcm.44.4.1459-1467.2006","article-title":"Single-assay combination of Epstein-Barr virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening","volume":"44","author":"Fachiroh","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/s0753-3322(97)83541-x","article-title":"Epstein-Barr virus and cancer","volume":"14","author":"Farrell","year":"2019","journal-title":"Annu. Rev. Pathol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/2042-4280-1-6","article-title":"Epstein-Barr virus genetics: talking about the BAC generation","volume":"1","author":"Feederle","year":"2010","journal-title":"Herpesviridae"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/15330338231169875","article-title":"Antibodies against Epstein-Barr virus as disease markers of gastric cancer: a systematic review","volume":"22","author":"Fontes-Lemus","year":"2023","journal-title":"Technol. Cancer Res. Treat."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1099\/jgv.0.000891","article-title":"Molecular diversity of IgG responses to Epstein-Barr virus proteins in asymptomatic Epstein-Barr virus carriers","volume":"98","author":"Goswami","year":"2017","journal-title":"J. Gen. Virol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/978-1-4939-2760-9_6","article-title":"Progress in yeast glycosylation engineering","volume":"1321","author":"Hamilton","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"B19","first-page":"4222","article-title":"Epstein-Barr virus-specific serology in immunologically compromised individuals","volume":"41","author":"Henle","year":"1981","journal-title":"Cancer Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1128\/jcm.37.10.3239-3244.1999","article-title":"Serodiagnosis of Epstein-Barr virus infection by using recombinant viral capsid antigen fragments and autologous gene fusion","volume":"37","author":"Hinderer","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1093\/annonc\/mdz231","article-title":"Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China","volume":"30","author":"Ji","year":"2019","journal-title":"Ann. Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1056\/nejmoa2301496","article-title":"Anti-Epstein-Barr virus BNLF2b for mass screening for nasopharyngeal cancer","volume":"389","author":"Li","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1093\/infdis\/jiy122","article-title":"Patterns of interindividual variability in the antibody repertoire targeting proteins across the Epstein-Barr virus proteome","volume":"217","author":"Liu","year":"2018","journal-title":"J. Infect. Dis."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01107-19","article-title":"Multilaboratory assessment of Epstein-Barr virus serologic assays: the case for standardization","volume":"57","author":"Liu","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179124","article-title":"Serological profiling of the EBV immune response in chronic fatigue syndrome using a peptide microarray","volume":"12","author":"Loebel","year":"2017","journal-title":"PloS One"},{"key":"B26","article-title":"Epstein-barr virus","volume-title":"Fields virology","author":"Longnecker","year":"2013"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/v15030656","article-title":"Virological markers in Epstein-Barr virus-associated diseases","volume":"15","author":"Lupo","year":"2023","journal-title":"Viruses"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1002\/ijc.35061","article-title":"Multiplex assays reveal anti-EBV antibody profile and its implication in detection and diagnosis of nasopharyngeal carcinoma","volume":"155","author":"Ma","year":"2024","journal-title":"Int. J. Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/82_2025_302","article-title":"Epstein-Barr virus (EBV)-specific humoral immune responses in health and disease","author":"Mautner","year":"2025","journal-title":"Curr. Top. Microbiol. Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/978-3-319-22834-1_10","article-title":"Epstein-Barr virus-specific humoral immune responses in health and disease","volume":"391","author":"Middeldorp","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/infdis\/156.1.26","article-title":"Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein-Barr virus infection","volume":"156","author":"Miller","year":"1987","journal-title":"J. Infect. Dis."},{"key":"B32","first-page":"69","article-title":"Statistics corner: a guide to appropriate use of correlation coefficient in medical research","volume":"24","author":"Mukaka","year":"2012","journal-title":"Malawi Med. J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-1-4939-6655-4_2","article-title":"Epstein-Barr virus: clinical diagnostics","volume":"1532","author":"Niller","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"B34","doi-asserted-by":"crossref","first-page":"889836","DOI":"10.3389\/fimmu.2022.889836","article-title":"Association between IgG responses against the nucleocapsid proteins of alphacoronaviruses and COVID-19 severity","volume":"13","author":"N\u00fcckel","year":"2022","journal-title":"Front. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jcv.2007.01.006","article-title":"Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis","volume":"38","author":"Nystad","year":"2007","journal-title":"J. Clin. Virol: Off. Publ. Pan Am. Soc. For. Clin. Virol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.1158\/1078-0432.ccr-22-1600","article-title":"Serologic profiling using an Epstein-Barr virus mammalian expression library identifies EBNA1 IgA as a prediagnostic marker for nasopharyngeal carcinoma","volume":"28","author":"Paudel","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/jmv.23253","article-title":"Longitudinal observation of Epstein-Barr virus antibodies in athletes during a competitive season","volume":"84","author":"Pottgiesser","year":"2012","journal-title":"J. Med. Virol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1099\/0022-1317-69-6-1217","article-title":"Characterization of the serological response in man to the latent membrane protein and the six nuclear antigens encoded by Epstein-Barr virus","volume":"69","author":"Rowe","year":"1988","journal-title":"J. Gen. Virol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jneuroim.2016.05.012","article-title":"Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: a peptide microarray-based case-control study","volume":"297","author":"Schlemm","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.21037\/anpc-21-12","article-title":"Utility of Epstein-Barr virus (EBV) antibodies as screening markers for nasopharyngeal carcinoma: a narrative review","volume":"6","author":"Sinha","year":"2022","journal-title":"Ann. Nasopharynx Cancer"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1099\/0022-1317-76-6-1393","article-title":"The disease associations of the antibody response against the Epstein-Barr virus transactivator protein ZEBRA can be separated into different epitopes","volume":"76","author":"Tedeschi","year":"1995","journal-title":"J. Gen. Virol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/infdis\/170.1.13","article-title":"Localization and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein","volume":"170","author":"Van Grunsven","year":"1994","journal-title":"J. Infect. Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.virol.2009.07.025","article-title":"EBV-positive human sera contain antibodies against the EBV BMRF-2 protein","volume":"393","author":"Xiao","year":"2009","journal-title":"Virology"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa0698","article-title":"Viral immunology. Comprehensive serological profiling of human populations using a synthetic human virome","volume":"348","author":"Xu","year":"2015","journal-title":"Science"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1093\/infdis\/jir645","article-title":"Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray","volume":"204","author":"Zheng","year":"2011","journal-title":"J. Infect. Dis."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1829807\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T05:41:48Z","timestamp":1779082908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1829807\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":45,"alternative-id":["10.3389\/fcimb.2026.1829807"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1829807","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"article-number":"1829807"}}